Form 4: Biolargo Executive Receives Stock Grant
Insider Transaction (Form 4)
Kenneth Reay Code, Chief Science Officer and a Director of Biolargo, Inc., reported multiple transactions in common stock on September 30, 2026.
Summary
- Grant/award: acquired 566,261 Common Stock at $0.08 ($45,301) on September 30, 2026; holds 26,974,580 after (Direct).
- Bona fide gift: disposed of 2,000,000 Common Stock on September 30, 2026; holds 24,974,580 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kenneth Reay Code — Director, Officer (Chief Science Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Grant/award | Common Stock | 566,261 | $0 | $45.3K | 26,974,580 |
| 2026-09-30 | Bona fide gift | Common Stock | 2,000,000 | — | — | 24,974,580 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Grant/award (566,261 shares) |
| 2026-09-30 | Bona fide gift (2,000,000 shares) |
Keywords
insider transaction, Form 4, BLGO, BIOLARGO, INC., neutral, Kenneth Reay Code
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.